Main Session
Sep
29
SS 33 - Advances in the Treatment of Brain Metastases
282 - Prospective Neurocognitive Outcomes in Patients with 5 to 30 Brain Metastases Treated with Stereotactic Radiosurgery (SRS): A Phase II Clinical Trial
Presenter(s)
Chia-Lin Tseng, MD - Sunnybrook Health Sciences Centre, Toronto, Ontario